these are old news, but still very relevant.

Novavax preclinical study: ”In the monkey study, the researchers did not find any evidence of the virus in the noses of the animals.”

Pfizer preclinical study: ”The BNT162b2 vaccination also cleared the nose of detectable viral RNA in 100% of the SARS-CoV-2 challenged rhesus macaques within 3 days after the infection”

0 days vs. 3 days. I think we have a winner! NVAX deserves a hold. $Novavax(NVAX)$ $Pfizer(PFE)$

免责声明:上述内容仅代表发帖人个人观点,不构成本平台的任何投资建议。

举报

评论1

  • 推荐
  • 最新
empty
暂无评论